Cantor Fitzgerald assumed coverage on shares of Mirum Pharmaceuticals (NASDAQ:MIRM – Free Report) in a report released on Tuesday, Marketbeat reports. The brokerage issued an overweight rating and a $50.00 price target on the stock. Other analysts have also issued reports about the company. JMP Securities reaffirmed a market outperform rating and issued a $70.00 […]
Mirum Pharmaceuticals, Inc (NASDAQ:MIRM) Sees Large Growth in Short Interest themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) SVP Jolanda Howe sold 915 shares of Mirum Pharmaceuticals stock in a transaction on Monday, July 3rd. The stock was sold at an average price of $25.65, for a total transaction of $23,469.75. Following the completion of the transaction, the senior vice president now owns 3,459 shares in […]